Decoy Therapeutics Inc. (NASDAQ: DCOY) — Healthcare · Share Price, Chart & Market Data
About: Decoy Therapeutics Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.43 (+0.09%)
DCOYDecoy Therapeutics Inc.
Loading watchlist status…
Trade DCOY now
Decoy Therapeutics Inc. share price
DCOY price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 9:02 am GMT+0
DCOY price performance
-7.106%
5D
-13.889%
1M
-30.662%
YTD
-30.234%
1Y
DCOY price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 9:02 am GMT+0
DCOY details
DCOY Market Signals